Expected costs per patient for base-case, high cost, and low cost estimate scenarios (in € for 2013).

Expected Cases for the period 2014–2016 by type of disease and institution.

Armando Arredondo (433339)
Raul Aviles (703802)

March 2015

Expected Cases for the period 2014–2016 by type of disease and institution.</p

Cost-of-illness analyses–Costs in categories and total costs per patient per year (in 2015 US$-PPP).

Thomas Grochtdreis (741198)
Hans-Helmut König (63648)
Alexander Dobruschkin (6054080)
Gunhild von Amsberg (2862761)
Judith Dams (6054083)

December 2018

Cost-of-illness analyses–Costs in categories and total costs per patient per year (in 2015 US$-PPP)....

Costs parameters of disease management used in the decision-tree model (in € for 2013).

Lionel Perrier (4736739)
Pauline Rascle (5066282)
Magali Morelle (4736748)
Maud Toulmonde (3728575)
Dominique Ranchere Vince (5066276)
Axel Le Cesne (4015952)
Philippe Terrier (304127)
Agnès Neuville (154344)
Pierre Meeus (3451424)
Fadila Farsi (3715723)
Françoise Ducimetière (346737)
Jean-Yves Blay (72864)
Isabelle Ray Coquard (5066279)
Jean-Michel Coindre (154348)

April 2018

Costs parameters of disease management used in the decision-tree model (in € for 2013).</p

Base-case estimated number of patients categorised in different phenotypes and age groups and their base-case cost of management.

Siew Chin Ong (9314213)
Joo Zheng Low (14043216)

July 2023

Base-case estimated number of patients categorised in different phenotypes and age groups and their ...

Total and per patient costs, split by category (UK base case).

Lara J. Wolfson (707558)
Anna Walker (707559)
Robert Hettle (707560)
Xiaoyan Lu (226200)
Chrispin Kambili (707561)
Andrew Murungi (707562)
Gerhart Knerer (707563)

March 2015

All costs reported in 2013 valuesBR: background regimen; TB: tuberculosisTotal and ...

Total 2013/14 expenditure by modelled disease (£000s except cost per prevalent case).

Adam D. M. Briggs (5278952)
Peter Scarborough (329722)
Jane Wolstenholme (398829)

May 2018

Total 2013/14 expenditure by modelled disease (£000s except cost per prevalent case).</p

Expected cost of next-generation sequencing (NGS) strategies vs. current standard of care (baseline scenario).

Jia Hui Chai (5108861)
Chun Kiat Lee (5108855)
Hong Kai Lee (416973)
Nicholas Wong (416069)
Kahwee Teo (5108867)
Chuen Seng Tan (206136)
Praveen Thokala (5108858)
Julian Wei-Tze Tang (416974)
Paul Anantharajah Tambyah (521300)
Vernon Min Sen Oh (5108864)
Tze Ping Loh (478886)
Joanne Yoong (228710)

April 2018

Expected cost of next-generation sequencing (NGS) strategies vs. current standard of care (baseli...

Predicted Mean Cost per Hospitalisation and Incremental Cost Associated with Number of Previous Hospitalisations.

Joshua Byrnes (835387)
Melinda Carrington (835388)
Yih-Kai Chan (835389)
Christine Pollicino (835390)
Natalie Dubrowin (835391)
Simon Stewart (386388)
Paul A. Scuffham (386394)

December 2015

Costs reported in Australian Dollars (2013)CV = cardiovascular; Std. Error = robust standa...

Estimated cost per patient per year (excluding the cost of antiviral therapy), by disease stage, in 2011 Euros.

Beat Müllhaupt (416436)
Philip Bruggmann (760024)
Florian Bihl (760025)
Sarah Blach (760026)
Daniel Lavanchy (739213)
Homie Razavi (760027)
David Semela (416437)
Francesco Negro (205592)

June 2015

(* Base costs were calculated as described above, ** Low costs represent the minimum cost associa...

Average annual cost per patient with heart failure and without heart failure in 2014.

Hyeonseok Cho (6112064)
Sung-Hee Oh (6112067)
Hankil Lee (2351089)
Hyun-Jai Cho (195420)
Hye-Young Kang (638660)

December 2018

Average annual cost per patient with heart failure and without heart failure in 2014.</p

Average costs per patient when introducing drugs and considering their efficacy.

Richard Cimler (6264623)
Petra Maresova (5534255)
Jitka Kuhnova (6264626)
Kamil Kuca (1474993)

January 2019

Average costs per patient when introducing drugs and considering their efficacy.</p

Estimated per patient costs (£000s) related specifically to HCV related complications (excluding any HCV therapy costs) stratified by age, discounting, fibrosis stage and SVR.

Phil McEwan (688067)
Thomas Ward (688068)
Hayley Bennett (688069)
Anupama Kalsekar (688070)
Samantha Webster (688071)
Michael Brenner (688072)
Yong Yuan (253559)

January 2015

Estimated per patient costs (£000s) related specifically to HCV related complications (excluding ...

Median direct medical costs (€) per year and per patient in the “Clinical signs” group and the “Screening” group.

Amélie Cariou (5680016)
Roman Rouzier (78764)
Sandrine Baffert (5680019)
Anne-Laure Soilly (5680022)
Delphine Hequet (4521211)

August 2018

Median direct medical costs (€) per year and per patient in the “Clinical signs” group and the “Scre...

Costs per 1,000 patients presenting for antenatal care and patient management as observed during evaluation study (Scenario ES).

Bruce A. Larson (111096)
Deophine Lembela-Bwalya (670441)
Rachael Bonawitz (670442)
Emily E. Hammond (670443)
Donald M. Thea (34844)
Julie Herlihy (670444)

December 2014

Costs per 1,000 patients presenting for antenatal care and patient management as observed during ...

Mean weighted cost per patient in US $ 2008 and standard deviation (number of RCT available).

Thibaut Caruba (424324)
Sandrine Katsahian (240861)
Catherine Schramm (572599)
Anaïs Charles Nelson (572600)
Pierre Durieux (70854)
Dominique Bégué (572601)
Yves Juillière (572602)
Olivier Dubourg (239190)
Nicolas Danchin (572603)
Brigitte Sabatier (424326)

June 2014

Mean weighted cost per patient in US $ 2008 and standard deviation (number of RCT available).</p

Expected Cases for the period 2014–2016 by type of disease and institution.

Armando Arredondo (433339)
Raul Aviles (703802)

March 2015

Expected Cases for the period 2014–2016 by type of disease and institution.</p

Cost-of-illness analyses–Costs in categories and total costs per patient per year (in 2015 US$-PPP).

Thomas Grochtdreis (741198)
Hans-Helmut König (63648)
Alexander Dobruschkin (6054080)
Gunhild von Amsberg (2862761)
Judith Dams (6054083)

December 2018

Cost-of-illness analyses–Costs in categories and total costs per patient per year (in 2015 US$-PPP)....

Costs parameters of disease management used in the decision-tree model (in € for 2013).

Lionel Perrier (4736739)
Pauline Rascle (5066282)
Magali Morelle (4736748)
Maud Toulmonde (3728575)
Dominique Ranchere Vince (5066276)
Axel Le Cesne (4015952)
Philippe Terrier (304127)
Agnès Neuville (154344)
Pierre Meeus (3451424)
Fadila Farsi (3715723)
Françoise Ducimetière (346737)
Jean-Yves Blay (72864)
Isabelle Ray Coquard (5066279)
Jean-Michel Coindre (154348)

April 2018

Costs parameters of disease management used in the decision-tree model (in € for 2013).</p

Base-case estimated number of patients categorised in different phenotypes and age groups and their base-case cost of management.

Siew Chin Ong (9314213)
Joo Zheng Low (14043216)

July 2023

Base-case estimated number of patients categorised in different phenotypes and age groups and their ...

Total and per patient costs, split by category (UK base case).

Lara J. Wolfson (707558)
Anna Walker (707559)
Robert Hettle (707560)
Xiaoyan Lu (226200)
Chrispin Kambili (707561)
Andrew Murungi (707562)
Gerhart Knerer (707563)

March 2015

All costs reported in 2013 valuesBR: background regimen; TB: tuberculosisTotal and ...

Total 2013/14 expenditure by modelled disease (£000s except cost per prevalent case).

Adam D. M. Briggs (5278952)
Peter Scarborough (329722)
Jane Wolstenholme (398829)

May 2018

Total 2013/14 expenditure by modelled disease (£000s except cost per prevalent case).</p

Expected cost of next-generation sequencing (NGS) strategies vs. current standard of care (baseline scenario).

Jia Hui Chai (5108861)
Chun Kiat Lee (5108855)
Hong Kai Lee (416973)
Nicholas Wong (416069)
Kahwee Teo (5108867)
Chuen Seng Tan (206136)
Praveen Thokala (5108858)
Julian Wei-Tze Tang (416974)
Paul Anantharajah Tambyah (521300)
Vernon Min Sen Oh (5108864)
Tze Ping Loh (478886)
Joanne Yoong (228710)

April 2018

Expected cost of next-generation sequencing (NGS) strategies vs. current standard of care (baseli...

Predicted Mean Cost per Hospitalisation and Incremental Cost Associated with Number of Previous Hospitalisations.

Joshua Byrnes (835387)
Melinda Carrington (835388)
Yih-Kai Chan (835389)
Christine Pollicino (835390)
Natalie Dubrowin (835391)
Simon Stewart (386388)
Paul A. Scuffham (386394)

December 2015

Costs reported in Australian Dollars (2013)CV = cardiovascular; Std. Error = robust standa...

Estimated cost per patient per year (excluding the cost of antiviral therapy), by disease stage, in 2011 Euros.

Beat Müllhaupt (416436)
Philip Bruggmann (760024)
Florian Bihl (760025)
Sarah Blach (760026)
Daniel Lavanchy (739213)
Homie Razavi (760027)
David Semela (416437)
Francesco Negro (205592)

June 2015

(* Base costs were calculated as described above, ** Low costs represent the minimum cost associa...

Average annual cost per patient with heart failure and without heart failure in 2014.

Hyeonseok Cho (6112064)
Sung-Hee Oh (6112067)
Hankil Lee (2351089)
Hyun-Jai Cho (195420)
Hye-Young Kang (638660)

December 2018

Average annual cost per patient with heart failure and without heart failure in 2014.</p

Average costs per patient when introducing drugs and considering their efficacy.

Richard Cimler (6264623)
Petra Maresova (5534255)
Jitka Kuhnova (6264626)
Kamil Kuca (1474993)

January 2019

Average costs per patient when introducing drugs and considering their efficacy.</p

Estimated per patient costs (£000s) related specifically to HCV related complications (excluding any HCV therapy costs) stratified by age, discounting, fibrosis stage and SVR.

Phil McEwan (688067)
Thomas Ward (688068)
Hayley Bennett (688069)
Anupama Kalsekar (688070)
Samantha Webster (688071)
Michael Brenner (688072)
Yong Yuan (253559)

January 2015

Estimated per patient costs (£000s) related specifically to HCV related complications (excluding ...

Median direct medical costs (€) per year and per patient in the “Clinical signs” group and the “Screening” group.

Amélie Cariou (5680016)
Roman Rouzier (78764)
Sandrine Baffert (5680019)
Anne-Laure Soilly (5680022)
Delphine Hequet (4521211)

August 2018

Median direct medical costs (€) per year and per patient in the “Clinical signs” group and the “Scre...

Costs per 1,000 patients presenting for antenatal care and patient management as observed during evaluation study (Scenario ES).

Bruce A. Larson (111096)
Deophine Lembela-Bwalya (670441)
Rachael Bonawitz (670442)
Emily E. Hammond (670443)
Donald M. Thea (34844)
Julie Herlihy (670444)

December 2014

Costs per 1,000 patients presenting for antenatal care and patient management as observed during ...

Mean weighted cost per patient in US $ 2008 and standard deviation (number of RCT available).

Thibaut Caruba (424324)
Sandrine Katsahian (240861)
Catherine Schramm (572599)
Anaïs Charles Nelson (572600)
Pierre Durieux (70854)
Dominique Bégué (572601)
Yves Juillière (572602)
Olivier Dubourg (239190)
Nicolas Danchin (572603)
Brigitte Sabatier (424326)

June 2014

Mean weighted cost per patient in US $ 2008 and standard deviation (number of RCT available).</p

Expected Cases for the period 2014–2016 by type of disease and institution.

Armando Arredondo (433339)
Raul Aviles (703802)

March 2015

Expected Cases for the period 2014–2016 by type of disease and institution.</p

Cost-of-illness analyses–Costs in categories and total costs per patient per year (in 2015 US$-PPP).

Thomas Grochtdreis (741198)
Hans-Helmut König (63648)
Alexander Dobruschkin (6054080)
Gunhild von Amsberg (2862761)
Judith Dams (6054083)

December 2018

Cost-of-illness analyses–Costs in categories and total costs per patient per year (in 2015 US$-PPP)....

Costs parameters of disease management used in the decision-tree model (in € for 2013).

Lionel Perrier (4736739)
Pauline Rascle (5066282)
Magali Morelle (4736748)
Maud Toulmonde (3728575)
Dominique Ranchere Vince (5066276)
Axel Le Cesne (4015952)
Philippe Terrier (304127)
Agnès Neuville (154344)
Pierre Meeus (3451424)
Fadila Farsi (3715723)
Françoise Ducimetière (346737)
Jean-Yves Blay (72864)
Isabelle Ray Coquard (5066279)
Jean-Michel Coindre (154348)

April 2018

Costs parameters of disease management used in the decision-tree model (in € for 2013).</p

Expected costs per patient for base-case, high cost, and low cost estimate scenarios (in € for 2013).

Abstract

Extracted data

Expected costs per patient for base-case, high cost, and low cost estimate scenarios (in € for 2013).

Abstract

Extracted data

Related items

Related items